Year 2020, Volume 33 , Issue 1, Pages 23 - 26 2020-01-31

Ventricular tachycardia ablation in patients with structural heart disease: single centre experience

Abdulkadir USLU [1] , Ayhan KUP [2] , Serdar DEMIR [3] , Kamil GULSEN [4] , Fethullah KAYAN [5] , Alper KEPEZ [6] , Taylan AKGUN [7]


Objective: We intended to report our institutional experience with ventricular tachycardia (VT) ablation in patients with structural heart disease. Patients and Methods: A total of 36 consecutive patients (31 male, age: 62.8 ± 13.2 years) who had undergone VT ablation in our institution between 01.01.2017 and 01.05.2019 were included in the analysis. Results: A total of 27 patients with the diagnosis of ischemic cardiomyopathy and 9 patients with the diagnosis of nonischemic cardiomyopathy had undergone VT ablation. VT ablation was successful in 32 (88.9%) patients. There were no major procedural complications; however, one patient with ischemic cardiomyopathy died 48 hours after the procedure because of post-ablation cardiogenic shock. Another patient with unsuccessful VT ablation died during hospitalization due to electrical storm. Endocardial ablation was performed in 23 (63.9%) patients and epicardial or combined endocardial and epicardial ablation was performed in 13 (36.1%) patients. Substrate ablation was the dominant strategy in 29 (80.6%) patients whereas activation mapping and isthmus ablation was performed in 7 (19.4%) patients. Conclusion: Our experience confirms the effectiveness and safety of VT ablation in patients with structural heart disease who are resistant to medical therapy and/or who receive recurrent implantable cardioverter-defibrillator shocks.
Ventricular tachycardia, Radiofrequency ablation, Cardiomyopathies
  • [1] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200. doi: 10.1093/eurheartj/ehw128.
  • [2] Dukkipati SR, Koruth JS, Choudry S, Miller MA, Whang W, Reddy VY. Catheter ablation of ventricular tachycardia in structural heart disease: Indications, strategies, and outcomes – part II. J Am Coll Cardiol 2017; 70: 2924-41. doi: 10.1016/j. jacc.2017.10.030.
  • [3] Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016; 375: 111-21. doi: 10.1056/NEJMoa1513614.
  • [4] Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357: 2657-65. doi: 10.1056/NEJMoa065457.
  • [5] Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010; 375: 3140. doi: 10.1016/S0140-6736(09)61755-4.
  • [6] Kuck KH, Tilz RR, Deneke T, et al. Impact of substrate modification by catheter ablation on implantable cardioverterdefibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 2017; 10: e004422. doi: 10.1161/CIRCEP.116.004422
  • [7] Tung R, Vaseghi M, Frankel DS, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm 2015; 12: 1997-2007. doi: 10.1016/j.hrthm.2015.05.036
  • [8] Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: The VISTA Randomized Multicenter Trial. J Am Coll Cardiol 2015; 66: 2872-82. doi: 10.1016/j.jacc.2015.10.026.
  • [9] Okubo K, Gigli L, Della Bella P. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy. J Arrhythm 2018; 34: 347-55. doi: 10.1002/joa3.12099.
Primary Language en
Subjects Medicine
Journal Section Original Research
Authors

Author: Abdulkadir USLU (Primary Author)
Institution: Kartal Kosuyolu Higher Speciality Heart and Vascular Diseases Training and Research Hospital
Country: Turkey


Author: Ayhan KUP
Institution: Kartal Kosuyolu Higher Speciality Heart and Vascular Diseases Training and Research Hospital
Country: Turkey


Author: Serdar DEMIR
Institution: Kartal Kosuyolu Higher Speciality Heart and Vascular Diseases Training and Research Hospital
Country: Turkey


Author: Kamil GULSEN
Institution: Kartal Kosuyolu Higher Speciality Heart and Vascular Diseases Training and Research Hospital
Country: Turkey


Author: Fethullah KAYAN
Institution: Mardin State Hospital
Country: Turkey


Author: Alper KEPEZ
Institution: Marmara University Training and Research Hospital
Country: Turkey


Author: Taylan AKGUN
Institution: Kartal Kosuyolu Higher Speciality Heart and Vascular Diseases Training and Research Hospital
Country: Turkey


Dates

Publication Date : January 31, 2020

Bibtex @research article { marumj681982, journal = {Marmara Medical Journal}, issn = {1019-1941}, eissn = {1309-9469}, address = {}, publisher = {Marmara University}, year = {2020}, volume = {33}, pages = {23 - 26}, doi = {10.5472/marumj.681982}, title = {Ventricular tachycardia ablation in patients with structural heart disease: single centre experience}, key = {cite}, author = {USLU, Abdulkadir and KUP, Ayhan and DEMIR, Serdar and GULSEN, Kamil and KAYAN, Fethullah and KEPEZ, Alper and AKGUN, Taylan} }
APA USLU, A , KUP, A , DEMIR, S , GULSEN, K , KAYAN, F , KEPEZ, A , AKGUN, T . (2020). Ventricular tachycardia ablation in patients with structural heart disease: single centre experience. Marmara Medical Journal , 33 (1) , 23-26 . DOI: 10.5472/marumj.681982
MLA USLU, A , KUP, A , DEMIR, S , GULSEN, K , KAYAN, F , KEPEZ, A , AKGUN, T . "Ventricular tachycardia ablation in patients with structural heart disease: single centre experience". Marmara Medical Journal 33 (2020 ): 23-26 <https://dergipark.org.tr/en/pub/marumj/issue/52168/681982>
Chicago USLU, A , KUP, A , DEMIR, S , GULSEN, K , KAYAN, F , KEPEZ, A , AKGUN, T . "Ventricular tachycardia ablation in patients with structural heart disease: single centre experience". Marmara Medical Journal 33 (2020 ): 23-26
RIS TY - JOUR T1 - Ventricular tachycardia ablation in patients with structural heart disease: single centre experience AU - Abdulkadir USLU , Ayhan KUP , Serdar DEMIR , Kamil GULSEN , Fethullah KAYAN , Alper KEPEZ , Taylan AKGUN Y1 - 2020 PY - 2020 N1 - doi: 10.5472/marumj.681982 DO - 10.5472/marumj.681982 T2 - Marmara Medical Journal JF - Journal JO - JOR SP - 23 EP - 26 VL - 33 IS - 1 SN - 1019-1941-1309-9469 M3 - doi: 10.5472/marumj.681982 UR - https://doi.org/10.5472/marumj.681982 Y2 - 2019 ER -
EndNote %0 Marmara Medical Journal Ventricular tachycardia ablation in patients with structural heart disease: single centre experience %A Abdulkadir USLU , Ayhan KUP , Serdar DEMIR , Kamil GULSEN , Fethullah KAYAN , Alper KEPEZ , Taylan AKGUN %T Ventricular tachycardia ablation in patients with structural heart disease: single centre experience %D 2020 %J Marmara Medical Journal %P 1019-1941-1309-9469 %V 33 %N 1 %R doi: 10.5472/marumj.681982 %U 10.5472/marumj.681982
ISNAD USLU, Abdulkadir , KUP, Ayhan , DEMIR, Serdar , GULSEN, Kamil , KAYAN, Fethullah , KEPEZ, Alper , AKGUN, Taylan . "Ventricular tachycardia ablation in patients with structural heart disease: single centre experience". Marmara Medical Journal 33 / 1 (January 2020): 23-26 . https://doi.org/10.5472/marumj.681982
AMA USLU A , KUP A , DEMIR S , GULSEN K , KAYAN F , KEPEZ A , AKGUN T . Ventricular tachycardia ablation in patients with structural heart disease: single centre experience. Marmara Med J. 2020; 33(1): 23-26.
Vancouver USLU A , KUP A , DEMIR S , GULSEN K , KAYAN F , KEPEZ A , AKGUN T . Ventricular tachycardia ablation in patients with structural heart disease: single centre experience. Marmara Medical Journal. 2020; 33(1): 26-23.